dihexa pnb-0408 c-met hgfr activator Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion HGF/c-MET pathway in cancer: from
HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene dihexa hgf c met agonist Structural basis of the activation of c MET receptor MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology Activated HGF c Met Axis in Head and Neck Cancer Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21




